Campion Sarah N, Johnson Rachel, Aleksunes Lauren M, Goedken Michael J, van Rooijen Nico, Scheffer George L, Cherrington Nathan J, Manautou José E
Dept. of Pharmaceutical Sciences, Univ. of Connecticut, 69 North Eagleville Rd., Unit 3092, Storrs, CT 06269-3092, USA.
Am J Physiol Gastrointest Liver Physiol. 2008 Aug;295(2):G294-304. doi: 10.1152/ajpgi.00541.2007. Epub 2008 Jun 12.
During acetaminophen (APAP) hepatotoxicity, increased expression of multidrug resistance-associated proteins 2, 3, and 4 (Mrp2-4) occurs. Mrp4 is the most significantly upregulated transporter in mouse liver following APAP treatment. Although the expression profiles of liver transporters following APAP hepatotoxicity are well characterized, the regulatory mechanisms contributing to these changes remain unknown. We hypothesized that Kupffer cell-derived mediators participate in the regulation of hepatic transporters during APAP toxicity. To investigate this, C57BL/6J mice were pretreated with clodronate liposomes (0.1 ml iv) to deplete Kupffer cells and then challenged with APAP (500 mg/kg ip). Liver injury was assessed by plasma alanine aminotransferase and hepatic transporter protein expression was determined by Western blot and immunohistochemistry. Depletion of Kupffer cells by liposomal clodronate increased susceptibility to APAP hepatotoxicity. Although increased expression of several efflux transporters was observed after APAP exposure, only Mrp4 was found to be differentially regulated following Kupffer cell depletion. At 48 and 72 h after APAP dosing, Mrp4 levels were increased by 10- and 33-fold, respectively, in mice receiving empty liposomes. Immunohistochemistry revealed Mrp4 staining confined to centrilobular hepatocytes. Remarkably, Kupffer cell depletion completely prevented Mrp4 induction by APAP. Elevated plasma levels of TNF-alpha and IL-1beta were also prevented by Kupffer cell depletion. These findings show that Kupffer cells protect the liver from APAP toxicity and that Kupffer cell mediators released in response to APAP are likely responsible for the induction of Mrp4.
在对乙酰氨基酚(APAP)肝毒性过程中,多药耐药相关蛋白2、3和4(Mrp2 - 4)的表达会增加。Mrp4是APAP处理后小鼠肝脏中上调最为显著的转运蛋白。尽管APAP肝毒性后肝脏转运蛋白的表达谱已得到充分表征,但导致这些变化的调节机制仍不清楚。我们推测库普弗细胞衍生的介质参与了APAP毒性期间肝脏转运蛋白的调节。为了研究这一点,用氯膦酸脂质体(0.1 ml静脉注射)预处理C57BL / 6J小鼠以耗尽库普弗细胞,然后用APAP(500 mg / kg腹腔注射)进行攻击。通过血浆丙氨酸转氨酶评估肝损伤,并通过蛋白质免疫印迹和免疫组织化学测定肝脏转运蛋白的表达。脂质体氯膦酸耗尽库普弗细胞会增加对APAP肝毒性的易感性。尽管在APAP暴露后观察到几种外排转运蛋白的表达增加,但仅发现Mrp4在库普弗细胞耗尽后受到差异调节。在APAP给药后48小时和72小时,接受空脂质体的小鼠中Mrp4水平分别增加了10倍和33倍。免疫组织化学显示Mrp4染色局限于小叶中央肝细胞。值得注意的是,库普弗细胞的耗尽完全阻止了APAP对Mrp4的诱导。库普弗细胞的耗尽也阻止了血浆中TNF-α和IL-1β水平的升高。这些发现表明库普弗细胞可保护肝脏免受APAP毒性,并且库普弗细胞响应APAP释放的介质可能是诱导Mrp4的原因。